ABBV Competitors & Alternatives
Compare AbbVie Inc with similar stocks in the same industry
Drug Manufacturers - General
ABBV
Main Stock$261.07
Tradestie Score
60
Market Cap
$431.71B
P/E Ratio
123.7
Revenue Growth
0.1%
Analyst Upside
-1.9%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$1213.91
|
$739.95B | 42.4 | 61 | Compare |
|
JNJ
Johnson & Johnson
|
$263.04
|
$448.07B | 29.4 | 65 | Compare |
|
NVO
Novo-Nordisk A/S
|
$50.43
|
$262.92B | 11.7 | 58 | Compare |
|
AZN
AstraZeneca PLC
|
$195.15
|
$261.56B | 29.2 | 62 | Compare |
|
NVS
Novartis AG
|
$159.90
|
$254.99B | 22.1 | 59 | Compare |
|
ABT
Abbott Laboratories
|
$95.40
|
$232.30B | 25.8 | 65 | Compare |
|
MRK
Merck & Co., Inc.
|
$129.56
|
$225.13B | 35.3 | 62 | Compare |
|
AMGN
Amgen Inc
|
$374.15
|
$160.70B | 25.1 | 69 | Compare |
|
PFE
Pfizer Inc.
|
$24.32
|
$154.70B | 18.2 | 60 | Compare |
|
GILD
Gilead Sciences Inc
|
$131.27
|
$137.92B | 17.2 | 67 | Compare |
More ABBV Analysis
Data updated: Jul 05, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry